Sanofi Contingent Value Rights
GCVRZ
GCVRZ was delisted on the 3rd of March, 2020.
109 hedge funds and large institutions have $34.4M invested in Sanofi Contingent Value Rights in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 9 closing their positions.
155% more capital invested
Capital invested by funds: $13.5M → $34.4M (+$20.9M)
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
3% more funds holding
Funds holding: 106 → 109 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 20
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$3.48M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$438K |
| 3 |
BHMP
Bardin Hill Management Partners
New York
|
+$385K |
| 4 |
ACM
Akanthos Capital Management
Woodland Hills,
California
|
+$115K |
| 5 |
PC
Permanens Capital
New York
|
+$19.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$61.8K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$43K |
| 3 |
DAM
Deltec Asset Management
New York
|
-$42.6K |
| 4 |
TI
Telemetry Investments
New York
|
-$23K |
| 5 |
TL
TowerView LLC
New York
|
-$17.2K |
GCVRZ Hedge Fund Activity: Q2 2016 in Review
109 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2016, worth a combined $34.4M — up 155% from $13.5M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new GCVRZ positions and 9 closed out — a net gain of 4 holders — while 10 added to existing stakes and 20 trimmed.
The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $3.48M. The largest seller was Bank of America, cutting an estimated $61.8K.
- 109 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2016, up from 106 in Q1 2016.
- Funds reported $34.4M of Sanofi Contingent Value Rights stock for Q2 2016, up 155% quarter-over-quarter.
- 13 funds opened new Sanofi Contingent Value Rights positions in Q2 2016 and 9 closed out, a net change of +4 holders.
- The largest Sanofi Contingent Value Rights buyer in Q2 2016 was TPG Group Holdings (SBS) Advisors, an estimated $3.48M added.
- The largest Sanofi Contingent Value Rights seller in Q2 2016 was Bank of America, an estimated $61.8K sold.
Based on aggregated 13F filings for Q2 2016.